For: | Daher R, Lefebvre T, Puy H, Karim Z. Extrahepatic hepcidin production: The intriguing outcomes of recent years. World J Clin Cases 2019; 7(15): 1926-1936 [PMID: 31423425 DOI: 10.12998/wjcc.v7.i15.1926] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i15/1926.htm |
Number | Citing Articles |
1 |
Runyu Liang, Qiang Tang, Wenjing Song, Mei Zhang, Lili Teng, Yuying Kang, Luwen Zhu, Feng Zhang. Electroacupuncture Preconditioning Reduces Oxidative Stress in the Acute Phase of Cerebral Ischemia-Reperfusion in Rats by Regulating Iron Metabolism Pathways. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/3056963
|
2 |
Jieou Nong, Hua Li, Yunfei Yang, Qiujie Lu, Yifan Sun, Qi Yin, Hongying He. Low serum hepcidin levels in women with polycystic ovary syndrome: evidence from meta-analysis. Gynecological Endocrinology 2024; 40(1) doi: 10.1080/09513590.2024.2375568
|
3 |
Poonam Sagar, Stanzin Angmo, Rajat Sandhir, Vikas Rishi, Hariom Yadav, Nitin Kumar Singhal. Effect of hepcidin antagonists on anemia during inflammatory disorders. Pharmacology & Therapeutics 2021; 226: 107877 doi: 10.1016/j.pharmthera.2021.107877
|
4 |
Ignasi Mora, Francesc Puiggròs, Florenci Serras, Katherine Gil-Cardoso, Xavier Escoté. Emerging models for studying adipose tissue metabolism. Biochemical Pharmacology 2024; 223: 116123 doi: 10.1016/j.bcp.2024.116123
|
5 |
Stanko Petrović, Dino Tarabar, Danica Ćujić, Dusica Stamenkovic, Marijana Petrović, Nemanja Rančić, Vesna Subota, Nenad Perišić, Mihailo Bezmarević. A Prospective Observational Study Analyzing the Diagnostic Value of Hepcidin-25 for Anemia in Patients with Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2024; 25(7): 3564 doi: 10.3390/ijms25073564
|
6 |
Yuki Hamada, Eiichi Hirano, Koji Sugimoto, Keizo Hanada, Taiichi Kaku, Naoki Manda, Kenichi Tsuchida. A farewell to phlebotomy—use of placenta-derived drugs Laennec and Porcine for improving hereditary hemochromatosis without phlebotomy: a case report. Journal of Medical Case Reports 2022; 16(1) doi: 10.1186/s13256-021-03230-5
|
7 |
Mawieh Hamad. Metabolic Dynamics in Host-Microbe Interaction. 2025; : 249 doi: 10.1007/978-981-96-1305-2_11
|
8 |
Naoto Taguchi, Suzuro Hitomi, Hitoshi Sato, Yoshinori Hayashi, Ikuko Shibuta, Koichi Iwata, Tatsuo Shirota, Masamichi Shinoda. Hepcidin promotes oral ulcer healing via amphiregulin production in rats. Journal of Dental Sciences 2024; doi: 10.1016/j.jds.2024.12.001
|
9 |
Mariangela Malerba, Carole Peyssonnaux. Rôle de l’hepcidine dans les infections cutanées. médecine/sciences 2020; 36(3): 222 doi: 10.1051/medsci/2020037
|
10 |
Yuki Hamada, Eiichi Hirano. Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis. 2023; doi: 10.5772/intechopen.107221
|
11 |
Zachary J. Hawula, Daniel F. Wallace, V. Nathan Subramaniam, Gautam Rishi. Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis. Pharmaceuticals 2019; 12(4): 170 doi: 10.3390/ph12040170
|
12 |
Isabella Zanella, Giulia Paiardi, Diego Di Lorenzo, Giorgio Biasiotto. Iron Absorption in Celiac Disease and Nutraceutical Effect of 7-Hydroxymatairesinol. Mini-Review. Molecules 2020; 25(9): 2041 doi: 10.3390/molecules25092041
|
13 |
Aicha Assouab, Ayyoub Kihel, Myriam Rouahi, Mathilde Larribau, Zoubida Karim, Khadija Akarid. Cutaneous leishmaniasis and iron metabolism: current insights and challenges. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1488590
|
14 |
Alenka Višnić, Dubravko Barišić, Gordana Čanadi Jurešić, Tina Sušanj Šepić, Neda Smiljan Severinski. Identification of urine biomarkers of endometriosis—Protein mass spectrometry. American Journal of Reproductive Immunology 2024; 91(5) doi: 10.1111/aji.13856
|
15 |
Feng Lin, Alex Tuffour, Guijie Hao, Frank Addai Peprah, Aixia Huang, Yang Zhou, Haiqi Zhang. Distinctive modulation of hepcidin in cancer and its therapeutic relevance. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1141603
|
16 |
Mete Ucdal, Ayse Burus, Basak Celtikci, Hatice Yasemin Balaban. A novel brick on the wall of non-alcoholic fatty liver disease (NAFLD): Nuclear receptor coactivator 4 (NCOA4). Medical Hypotheses 2023; 181: 111203 doi: 10.1016/j.mehy.2023.111203
|